|
Name |
Methyl pentadecanoate
|
Molecular Formula | C16H32O2 | |
IUPAC Name* |
methyl pentadecanoate
|
|
SMILES |
CCCCCCCCCCCCCCC(=O)OC
|
|
InChI |
InChI=1S/C16H32O2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18-2/h3-15H2,1-2H3
|
|
InChIKey |
XIUXKAZJZFLLDQ-UHFFFAOYSA-N
|
|
Synonyms |
METHYL PENTADECANOATE; 7132-64-1; Pentadecanoic acid, methyl ester; Pentadecanoic acid methyl ester; Methyl n-pentadecanoate; n-Pentadecanoic acid methyl ester; MFCD00008989; 8K0ZV6FAIZ; pentadecanoic acid-methyl ester; 68937-84-8; UNII-8K0ZV6FAIZ; EINECS 230-430-6; EINECS 273-095-1; pentadecanoic acid methyl; AI3-36452; Methyl pentadecanoate, 98%; SCHEMBL246530; CHEMBL1900809; DTXSID4040769; CDAA-251015M; CHEBI:142657; Methyl pentadecanoate, >=98.5%; Pentanedecanoic acid, methyl ester; STL454743; ZINC38141470; AKOS002676182; CS-W004289; HY-W004289; NCGC00164331-01; AS-57591; Methyl pentadecanoate, analytical standard; SY051773; DB-055514; FT-0636359; P0869; H10934; A914605; Q27270652; 93612FD5-1EFF-4869-9B03-8B8BAD63EE28
|
|
CAS | 7132-64-1 | |
PubChem CID | 23518 | |
ChEMBL ID | CHEMBL1900809 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 256.42 | ALogp: | 7.4 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 14 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 18 | QED Weighted: | 0.32 |
Caco-2 Permeability: | -4.728 | MDCK Permeability: | 0.00001720 |
Pgp-inhibitor: | 0.071 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.983 |
30% Bioavailability (F30%): | 0.995 |
Blood-Brain-Barrier Penetration (BBB): | 0.571 | Plasma Protein Binding (PPB): | 97.21% |
Volume Distribution (VD): | 1.69 | Fu: | 1.63% |
CYP1A2-inhibitor: | 0.77 | CYP1A2-substrate: | 0.217 |
CYP2C19-inhibitor: | 0.519 | CYP2C19-substrate: | 0.134 |
CYP2C9-inhibitor: | 0.284 | CYP2C9-substrate: | 0.937 |
CYP2D6-inhibitor: | 0.101 | CYP2D6-substrate: | 0.073 |
CYP3A4-inhibitor: | 0.4 | CYP3A4-substrate: | 0.073 |
Clearance (CL): | 5.197 | Half-life (T1/2): | 0.337 |
hERG Blockers: | 0.203 | Human Hepatotoxicity (H-HT): | 0.027 |
Drug-inuced Liver Injury (DILI): | 0.306 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.028 | Maximum Recommended Daily Dose: | 0.018 |
Skin Sensitization: | 0.952 | Carcinogencity: | 0.072 |
Eye Corrosion: | 0.954 | Eye Irritation: | 0.972 |
Respiratory Toxicity: | 0.904 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000271 | 0.944 | D07ILQ | 0.632 | ||||
ENC000604 | 0.941 | D0Z5SM | 0.615 | ||||
ENC000496 | 0.895 | D05ATI | 0.531 | ||||
ENC000495 | 0.882 | D0O1PH | 0.500 | ||||
ENC000280 | 0.850 | D00FGR | 0.482 | ||||
ENC000260 | 0.824 | D00AOJ | 0.475 | ||||
ENC000497 | 0.810 | D00MLW | 0.406 | ||||
ENC001160 | 0.783 | D0P1RL | 0.402 | ||||
ENC000474 | 0.773 | D0XN8C | 0.392 | ||||
ENC000419 | 0.770 | D0T9TJ | 0.380 |